• About Us
  • Why MenaQ7®️
  • K2 Science
  • News & Events
    • News & Press
    • Event Calendar
  • Partners
  • #5613 (no title)
Menu
  • About Us
  • Why MenaQ7®️
  • K2 Science
  • News & Events
    • News & Press
    • Event Calendar
  • Partners
  • #5613 (no title)
Contact Us
  • About Us
  • Why MenaQ7®️
  • K2 Science
  • News & Events
    • News & Press
    • Event Calendar
  • Partners
  • Contact Us
Menu
  • About Us
  • Why MenaQ7®️
  • K2 Science
  • News & Events
    • News & Press
    • Event Calendar
  • Partners
  • Contact Us
Contact Us

Featured story

New Partnership & Launch in China

New exclusive MenaQ7® product introduced to 150 invited distributors.

Nattopharma was honored to participate in a launching conference commemorating the first product introduced in China featuring MenaQ7® Vitamin K2 as MK-7.

FishBurg, a leading Chinese dietary supplement producer with a strong position in the Calcium/Vitamin D3 (VD3) segment, signed a partnership and supply agreement with NattoPharma, world leaders in Vitamin K2 as MK-7 research and development, on November 28th in Guangzhou. During this event, FishBurg officially launched its new Blue Hat-registered Calcium/VD3/MenaQ7 Vitamin K2 supplement for bone health to the Chinese market.

The event was attended by 150 distributors from across China, who will promote the new FishBurg product via pharmacies and other Chinese dietary supplement channels. During the event, FishBurg, NattoPharma, and the Norwegian council made presentations that mark the start of this important partnership and entry into the Chinese market. The event culminated with the signing of a strategic partnership and supply agreement between FishBurg and NattoPharma, and a ribbon-cutting ceremony.

“The product launch is a clear indication of the commitment from both parties,” says Daniel Rosenbaum, NattoPharma CEO. “The event created excitement around MenaQ7 Vitamin K2, which has amazing market potential in China.”

NattoPharma’s Chinese distributor partner Prochin hosted the event. According to Jordan Yang, the commercial director of Prochin, distributors were excited to learn about MenaQ7® arrival in China.

“FishBurg is quite confident that the newly launched Calcium/VD3/MenaQ7 Vitamin K2 product will have a very impressive impact on the Chinese nutritional market, bringing the benefits of bone and cardiovascular health to all customers,” said by Youwen Chen, the CEO of FishBurg.

Share on:
Share on facebook
Share on twitter
Share on linkedin

Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam nonumy eirmod tempor

NattoPharma
  • Mission & Purpose
  • K2 Timeline
  • Management Team
  • K2 Science
  • K2 in Numbers
  • Mission & Purpose
  • K2 Timeline
  • Management Team
  • K2 Science
  • K2 in Numbers
MenaQ7®️
  • Why MenaQ7®️
  • Quality Statement
  • Benefits
  • Partner Benefits
News & Events
  • News & Press
  • Event Calendar
Contact Us

Let's improve health!

How can we help?
  • Oslo, Norway (Main)
  • New Jersey, USA
  • Contact Us
© Copyright 2022 NattoPharma.
All rights reserved

We value your privacy

We access information on a device, such as cookies and process personal data, such as unique identifiers and standard information sent by a device for personalised ads and content, ad and content measurement, and audience insights, as well as to develop and improve products.

With your permission we and our partners may use precise geolocation data and identification through device scanning. You may click to consent to our and our partners’ processing as described above. Alternatively you may click to refuse to consent or access more detailed information and change your preferences before consenting.

Please note that some processing of your personal data may not require your consent, but you have a right to object to such processing. Your preferences will apply to this website only. You can change your preferences at any time by returning to this site or visit our privacy policy.

Agree
Disagree